Postmarketing Study Commitment Trends for New Drugs: An Analysis of NMEs Approved in 2008
Given that the FDA Amendments Act of 2007 (FDAAA) took effect in late March 2008, the 2008 class of approved NMEs offered an early glimpse into how anxiously the FDA would wield its newly found powers regarding postmarketing requirements and risk evaluation and mitigation strategies (REMS).
World Drug Safety Congress
April 22 - 23, 2009
Washington, DC
Webinar: Product Development Strategies for Follow-on Biologics
Wednesday, April 23, 2009
12 pm ET • 9 am PT • 90 minutes
European Generic Medicines Association: Annual Symposium on Biosimilars
April 23 - 24, 2009
London, UK
Partnerships with CROs and Other Outsourcing Providers
April 28 - 30, 2009
Orlando, FL
Visit PAREXEL and Perceptive Informatics at booths 240 & 241.
CHI Patient Recruitment in Clinical Trials
May 11 - 12, 2009
Boston, MA
Exploratory Clinical Development World Europe
May 13 - 14, 2009
London, UK
CphI Building Long-term Strategic CRO Partnerships
May 19 - 20, 2009
Berlin, Germany
IIR Partnerships in Clinical Trials
May 20 - 21, 2009
Sydney, Australia
SLEEP 2009
June 06 - 11, 2009
Seattle, WA
DIA 45th Annual Meeting
June 21 - 25, 2009
San Diego, California